Final results of a phase II study of sunitinib as second- line therapy in malignant pleural mesothelioma (MPM)

A. K. Nowak; M. Millward; R. J. Francis; A. Hasani; A. A. van der Schaaf; T. Seguard; A. W. Musk; M. J. Byrne

doi:10.1200/jco.2010.28.15_suppl.7036

Final results of a phase II study of sunitinib as second- line therapy in malignant pleural mesothelioma (MPM)

A. K. Nowak
, M. Millward
, R. J. Francis
, A. Hasani
, A. A. van der Schaaf
, T. Seguard
, A. W. Musk
, M. J. Byrne

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

Original language	English
Number of pages	1
Journal	Journal of Clinical Oncology
Volume	28
Issue number	15
DOIs	https://doi.org/10.1200/jco.2010.28.15_suppl.7036
Publication status	Published - 20 May 2010
Externally published	Yes

Access to Document

10.1200/jco.2010.28.15_suppl.7036

Cite this

@article{62a7084c50fa4cc78d613990350e4ce2,

title = "Final results of a phase II study of sunitinib as second- line therapy in malignant pleural mesothelioma (MPM)",

author = "Nowak, \{A. K.\} and M. Millward and Francis, \{R. J.\} and A. Hasani and \{van der Schaaf\}, \{A. A.\} and T. Seguard and Musk, \{A. W.\} and Byrne, \{M. J.\}",

year = "2010",

month = may,

day = "20",

doi = "10.1200/jco.2010.28.15\_suppl.7036",

language = "English",

volume = "28",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams \& Wilkins",

number = "15",

}

TY - JOUR

T1 - Final results of a phase II study of sunitinib as second- line therapy in malignant pleural mesothelioma (MPM)

AU - Nowak, A. K.

AU - Millward, M.

AU - Francis, R. J.

AU - Hasani, A.

AU - van der Schaaf, A. A.

AU - Seguard, T.

AU - Musk, A. W.

AU - Byrne, M. J.

PY - 2010/5/20

Y1 - 2010/5/20

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=uwapure5-25&SrcAuth=WosAPI&KeyUT=WOS:000208852004580&DestLinkType=FullRecord&DestApp=WOS

U2 - 10.1200/jco.2010.28.15_suppl.7036

DO - 10.1200/jco.2010.28.15_suppl.7036

M3 - Abstract/Meeting Abstract

SN - 0732-183X

VL - 28

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 15

ER -

Final results of a phase II study of sunitinib as second- line therapy in malignant pleural mesothelioma (MPM)

Access to Document

Other files and links

Cite this